论文部分内容阅读
目的:妈富隆用于药物流产后的临床效果。方法:对120例药物流产患者,随机分为2组,药物流产后即服用妈富隆者68例为观察组,未服用妈富隆者52例为对照组,对照分析,观察疗效。结果:观察组及对照组平均出血天数为(9.44±5.75)d、(15.72±6.57)d,P<0.01,出血量比月经量多者分别占13.2%、28.8%,出血量比月经量少分别为30.9%、21.2%,完全流产、不全流产分别为97.06%、2.94%;82.69%、17.3%;月经复潮时间(26±4.6)d、(33±7.5)d。结论:妈富隆减少药物流产后阴道出血时间和出血时间疗效显著,并且可以降低不全流产率,调整月经周期,减少药物流产后首次月经来潮经量,促进卵巢功能恢复,不良反应小,值得推广。
Objective: Marvelon is used in the clinical effect after medical abortion. Methods: A total of 120 cases of medical abortion were randomly divided into two groups. 68 cases were treated with Marvelon after abortion, and 52 cases without Marvelon were taken as control group. The curative effect was observed and compared. Results: The average number of bleeding days in observation group and control group was (9.44 ± 5.75) days, (15.72 ± 6.57) days, P <0.01. The bleeding volume was 13.2% and 28.8% Respectively, 30.9%, 21.2%, complete abortion, incomplete abortion were 97.06%, 2.94%; 82.69%, 17.3%; menstrual resuscitation time (26 ± 4.6) d, (33 ± 7.5) d. Conclusion: Marvelon can reduce vaginal bleeding time and hemorrhage time after medical abortion. It can reduce incomplete abortion rate, adjust menstrual cycle, reduce the first menstrual flow after medical abortion, and promote ovarian function recovery. It is worth to popularize.